Multi-payload antibody-drug conjugates for photothermal dynamic and chemotherapy of HER2-positive breast cancer
HER2-positive breast cancer is highly aggressive and has a poor prognosis in clinical treatment primarily due to the overexpression of HER2 protein. Trastuzumab can significantly improve the therapeutic outcome for HER2-positive breast cancer, but 70% of patients develop drug resistance. Trastuzumab...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-08-01
|
| Серія: | Materials Today Bio |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2590006426006009 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|